AgeX Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

AgeX Therapeutics General Information

Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. The company's product pipeline includes two cell-based and two iTR-based product candidates in development. Its lead cell-based therapeutic candidates in development are AGEX-BAT1 and AGEX-VASC1. Its lead small molecule drug-based therapeutic candidate for iTRTM in discovery is AGEX-iTR1547.

Contact Information

Website
www.agexinc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1010 Atlantic Avenue
  • Suite 102
  • Alameda, CA 94501
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1010 Atlantic Avenue
  • Suite 102
  • Alameda, CA 94501
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AgeX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 26-Mar-2024 Completed Generating Revenue
5. IPO 29-Nov-2018 Completed Generating Revenue
4. Merger/Acquisition 08-Nov-2018 Completed Startup
3. Grant 02-May-2018 Completed Startup
2. Grant 15-Apr-2018 $11.1M $10.8M Completed Startup
1. Early Stage VC 02-Aug-2017 $10.8M $10.8M Completed Startup
To view AgeX Therapeutics’s complete valuation and funding history, request access »

AgeX Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics
Drug Discovery
Alameda, CA
9 As of 2022

Plymouth Meeting, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AgeX Therapeutics Competitors (43)

One of AgeX Therapeutics’s 43 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Capricor Therapeutics Formerly VC-backed San Diego, CA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Barinthus Biotherapeutics Formerly VC-backed Altrincham, United Kingdom
Mesoblast Corporation Melbourne, Australia
You’re viewing 5 of 43 competitors. Get the full list »

AgeX Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AgeX Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
IBS Capital Hedge Fund Minority
Angel (individual) Minority
Juvenescence VC-Backed Company Majority
Kizoo Technology Capital Venture Capital Minority
National Institutes of Neurological Disorders and Stroke Government
To view AgeX Therapeutics’s complete investors history, request access »

AgeX Therapeutics Investments & Acquisitions (2)

AgeX Therapeutics’s most recent deal was a Reverse Merger with Serina Therapeutics for . The deal was made on 26-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Serina Therapeutics 26-Mar-2024 Reverse Merger Drug Discovery
Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) 16-Aug-2019 Corporate Asset Purchase Buildings and Property
To view AgeX Therapeutics’s complete investments and acquisitions history, request access »

AgeX Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view AgeX Therapeutics’s complete esg history, request access »

AgeX Therapeutics FAQs

  • When was AgeX Therapeutics founded?

    AgeX Therapeutics was founded in 2017.

  • Where is AgeX Therapeutics headquartered?

    AgeX Therapeutics is headquartered in Alameda, CA.

  • What is the size of AgeX Therapeutics?

    AgeX Therapeutics has 9 total employees.

  • What industry is AgeX Therapeutics in?

    AgeX Therapeutics’s primary industry is Drug Discovery.

  • Is AgeX Therapeutics a private or public company?

    AgeX Therapeutics is a Private company.

  • What is AgeX Therapeutics’s current revenue?

    The current revenue for AgeX Therapeutics is .

  • How much funding has AgeX Therapeutics raised over time?

    AgeX Therapeutics has raised $10.8M.

  • Who are AgeX Therapeutics’s investors?

    IBS Capital, , Juvenescence, Kizoo Technology Capital, and National Institutes of Neurological Disorders and Stroke have invested in AgeX Therapeutics.

  • Who are AgeX Therapeutics’s competitors?

    Inovio Pharmaceuticals, Capricor Therapeutics, Sangamo Therapeutics, Barinthus Biotherapeutics, and Mesoblast are some of the 43 competitors of AgeX Therapeutics.

  • When was AgeX Therapeutics acquired?

    AgeX Therapeutics was acquired on 26-Mar-2024.

  • Who acquired AgeX Therapeutics?

    AgeX Therapeutics was acquired by Serina Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process